Enzo Biochem, Inc. (ENZ) Reports Q2 Loss of $0.04

Enzo Biochem, Inc. (NYSE: ENZ) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $25 million, versus $23.7 million reported last year.

For earnings history and earnings-related data on Enzo Biochem, Inc. (ENZ) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• InspireMD (NSPR) Tops Q2 EPS by 1c
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c